Lymphogranuloma venereum - Annual Epidemiological Report for 2016
Lymphogranuloma venereum (LGV) is a systemic STI caused by Chlamydia trachomatis serovars L1, L2, or L3. In 2016, 2 043 cases of LGV were reported in 22 countries.
Chlamydia - Annual Epidemiological Report for 2015
In 2015, 394 163 cases of chlamydia infection were reported in 27 EU/EEA Member States.
Lymphogranuloma venereum - Annual Epidemiological Report for 2015
In 2015, 1 787 cases of Lymphogranuloma venereum (LGV) were reported in 23 countries.
Lymphogranuloma venereum - Annual Epidemiological Report 2016 [2014 data]
In 2014, 1 416 cases of LGV were reported in 21 countries.
Public health guidance on chlamydia control in Europe
This document updates the 2009 ECDC guidance on chlamydia control in Europe. The aim of this guidance is to support Member States to develop, implement or improve strategies for chlamydia control.
Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey
van den Broek, I.V., Sfetcu, O., van der Sande, M.A., Andersen, , B., Herrmann, B., Ward, H., Gotz, H.M., Uuskula, A., Woodhall, S.C., Redmond, S.M., Amato-Gauci, A.J., Low, N., van Bergen, J.E.
Sexually transmitted infections in Europe 2013
This ECDC surveillance report on STI in Europe describes the epidemiological features and basic trends of the five STI under EU surveillance, Chlamydia trachomatis infection, gonorrhoea, syphilis, congenital syphilis, and lymphogranuloma venereum.
Public health guidance on HIV and STI prevention among men who have sex with men
This guidance, based on a systematic review of the literature and expert opinion, suggests that there is good evidence to ensure that some key components are considered for inclusion in national and sub-national public health programmes in countries in Europe.
Chlamydia control in Europe: Qualitative evaluation of the impact of the 2009 ECDC guidance
This technical report describes the evaluation of the impact of the 2009 guidance document on policymaking in Member States and presents recommendations for a revised version of the guidance.